Gabelnick HL - Search Results

1

A comparison of techniques to assess cervicovaginal irritation and evaluation of the variability between two observers.

Ballagh SA, Mauck CK, Henry D, Archer DF, Abercrombie T, Callahan MM, Gabelnick HL. Ballagh SA, et al. Among authors: gabelnick hl. Contraception. 2004 Sep;70(3):241-9. doi: 10.1016/j.contraception.2004.03.002. Contraception. 2004. PMID: 15325894 Clinical Trial.

2

Lea's Shield: a study of the safety and efficacy of a new vaginal barrier contraceptive used with and without spermicide.

Mauck C, Glover LH, Miller E, Allen S, Archer DF, Blumenthal P, Rosenzweig A, Dominik R, Sturgen K, Cooper J, Fingerhut F, Peacock L, Gabelnick HL. Mauck C, et al. Among authors: gabelnick hl. Contraception. 1996 Jun;53(6):329-35. doi: 10.1016/0010-7824(96)00081-9. Contraception. 1996. PMID: 8773419 Free article. Clinical Trial.

3

The effect of one injection of Depo-Provera on the human vaginal epithelium and cervical ectopy.

Mauck CK, Callahan MM, Baker J, Arbogast K, Veazey R, Stock R, Pan Z, Morrison CS, Chen-Mok M, Archer DF, Gabelnick HL. Mauck CK, et al. Among authors: gabelnick hl. Contraception. 1999 Jul;60(1):15-24. doi: 10.1016/s0010-7824(99)00058-x. Contraception. 1999. PMID: 10549448

4

The use of colposcopy in assessing vaginal irritation in research.

Mauck CK, Baker JM, Birnkrant DB, Rowe PJ, Gabelnick HL. Mauck CK, et al. Among authors: gabelnick hl. AIDS. 2000 Oct 20;14(15):2221-7. doi: 10.1097/00002030-200010200-00002. AIDS. 2000. PMID: 11089609 Review.

5

First phase 1 double-blind, placebo-controlled, randomized rectal microbicide trial using UC781 gel with a novel index of ex vivo efficacy.

Anton PA, Saunders T, Elliott J, Khanukhova E, Dennis R, Adler A, Cortina G, Tanner K, Boscardin J, Cumberland WG, Zhou Y, Ventuneac A, Carballo-Diéguez A, Rabe L, McCormick T, Gabelnick H, Mauck C, McGowan I. Anton PA, et al. PLoS One. 2011;6(9):e23243. doi: 10.1371/journal.pone.0023243. Epub 2011 Sep 28. PLoS One. 2011. PMID: 21969851 Free PMC article. Clinical Trial.

6

Contraceptive efficacy and acceptability of the female condom.

Farr G, Gabelnick H, Sturgen K, Dorflinger L. Farr G, et al. Am J Public Health. 1994 Dec;84(12):1960-4. doi: 10.2105/ajph.84.12.1960. Am J Public Health. 1994. PMID: 7998637 Free PMC article.

7

Microbicides 2000 conference. Panel discussion: streamlining the process and regulatory issues. Microbicide research-streamlining the process, setting the stage.

Gabelnick HL. Gabelnick HL. AIDS. 2001 Feb;15 Suppl 1:S65-6. doi: 10.1097/00002030-200102001-00096. AIDS. 2001. PMID: 11407324 No abstract available.

8

Current contraceptive research.

Schwartz JL, Gabelnick HL. Schwartz JL, et al. Among authors: gabelnick hl. Perspect Sex Reprod Health. 2002 Nov-Dec;34(6):310-6. Perspect Sex Reprod Health. 2002. PMID: 12558094 Review. No abstract available.

9

The promise of public/private sector collaboration in the development of vaginal microbicides.

Gabelnick HL, Harper MJ. Gabelnick HL, et al. Int J Gynaecol Obstet. 1999 Dec;67 Suppl 2:S31-8. doi: 10.1016/s0020-7292(99)00144-7. Int J Gynaecol Obstet. 1999. PMID: 10661739

10

Long-acting hormonal contraception.

Benagiano G, Gabelnick H, Brosens I. Benagiano G, et al. Womens Health (Lond). 2015 Nov;11(6):749-57. doi: 10.2217/whe.15.68. Epub 2015 Dec 2. Womens Health (Lond). 2015. PMID: 26626534 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21 results

Search Page